FDA Inspection
Merck Serono SAMerck Serono SA – FDA Inspection, Jun 16, 2011
Record Details
This FDA Inspection record concerns Merck Serono SA, with an inspection on June 16, 2011, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Merck Serono SA
- Inspection Date
- June 16, 2011
- Product Type
- Drugs
View Company Profile
ID · ec28250f-7ba3-4d9b-a5ef-00d359890f9f
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 732616
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Merck Serono SA
8| Date | Classification | Office | Project area |
|---|---|---|---|
| November 25, 2025 | Not classified | Office of Inspections and Investigations | |
| May 2, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 18, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 9, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 6, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Merck Serono SA
- FDA Inspection 1298388 - 2025-11-25
- FDA Inspection 1209187 - 2023-05-02
- FDA Inspection 1122463 - 2020-02-18
- FDA Inspection 1051545 - 2018-05-09
- FDA Inspection 947757 - 2015-11-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.